Sarcomas in organ allograft recipients

Transplantation

Volumn 60, Issue 12, 1995, Pages 1485-1491

  Penn, Israel ^a,b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANGIOSARCOMA; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DERMATOFIBROMA; FEMALE; FIBROSARCOMA; FOLLOW UP; HUMAN; KAPOSI SARCOMA; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; ORGAN TRANSPLANTATION; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; RECIPIENT; RHABDOMYOSARCOMA; SARCOMA; SCHOOL CHILD;

CONTINENTAL POPULATION GROUPS; HUMANS; ORGAN TRANSPLANTATION; REGISTRIES; SARCOMA;

EID: 0029594585     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199560120-00020     Document Type: Article

References (48)

1. Penn I. Kaposi’s sarcoma in organ transplant recipients: report of 20 cases. Transplantation 1979; 27: 8.
2. Penn I. Kaposi’s sarcoma in immunosuppressed patients. J Clin Lab Immunol 1983; 12: 1.
3. Penn I. Kaposi’s sarcoma—etiology: immunodeficiency. In Ziegler JL, and Dorfman RF, eds. Kaposi’s sarcoma, pathophysiology and clinical Management. New York: Dekker, 1988: 129.
4. Penn I. Malignancy. Surg Clin N Am 1994; 74: 1247.
5. Penn I. Principles of tumor immunity: immunocompetence and cancer. In Devita VT Jr, Heilman S, Rosenberg SA, eds. Biologic therapy of cancer, 2nd ed. Philadelphia: Lippincott, 1995: 103.
6. Penn I. Effects of immunosuppression on pre-existing cancers. Transplantation 1993; 55: 742.
7. Kumar P, Pearson JE, Martin DH, et al. Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome. Ann Int Med 1987; 106: 244.
8. Parrott NR, Scott PD, Freemont AJ, Johnson RWG. Angiosarcoma in an arteriovenous fistula following successful renal transplantation—case report. Transplantation 1993; 55: 676.
9. Byers RJ, McMahon RFT, Freemont AJ, Parrott NR, Newstead CG. Epithelioid angiosarcoma arising in an arteriovenous fistula. Histopathology 1992; 21: 87.
10. Keane MM, Carney DN. Angiosarcoma arising from a defunctionalized arteriovenous fistula. J Urol 1993; 149: 364.
11. Conlon PJ, Daly T, Doyle G, Carmody M. Angiosarcoma at the site of a ligated arteriovenous fistula in a renal transplant recipient. Nephrol Dial Transplant 1993; 8: 259.
12. Harwood AR, Osoba D, Hofstader SL, et al. Kaposi’s sarcoma in recipient of renal transplant. Am J Med 1979; 67: 759.
13. Montagnino G, Bencini PL, Tarantino A, et al. Clinical features and course of Kaposi’s sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol 1994; 14: 121.
14. Al-Sulaiman MH, Al-Khader AA. Kaposi’s sarcoma in renal transplant recipients. Transplant Sci 1994; 4: 46.
15. Qunibi W, Akhtar M, Sheth K, et al. Kaposi’s sarcoma: the most common tumor after renal transplantation in Saudi Arabia. Am J Med 1988; 84: 225.
16. Farge D and the Collaborative Transplantation Research Group of the Ile de France. Kaposi’s sarcoma in organ transplant recipients. Eur J Med 1993; 2: 339.
17. Ziegler JL, Dorfman RF. Overview of Kaposi’s sarcoma: History, epidemiology, and biomedical features. In Ziegler JL, Dorfman RF, eds. Kaposi’s sarcoma: pathophysiology and clinical management. New York: Dekker 1988: 2.
18. Al-Sulaiman MH, Mousa DH, Rassoul Z, Abdalla AH, Abdur Rehman M, Al-Khader AA. Transplant-related Kaposi’s sarcoma in children. Nephrol Dial Transplant 1994; 9: 443.
19. Al-Sulaiman MH, Mousa DH, Dhar JM, Al-Khader AA. Does regressed posttransplantation Kaposi’s sarcoma recur following reintroduction of immunosuppression? Am J Nephrol 1992; 12: 384.
20. Myers BD, Kessler E, Levi J, Pick A, Rosenfeld JB. Kaposi’s sarcoma in kidney transplant recipients. Arch Int Med 1974; 133: 307.
21. Margolius L, Stein M, Spencer D, Bezwoda WR. Kaposi’s sarcoma in renal transplant recipients: experience at Johannesburg Hospital 1966-1989. South Afr Med J 1994; 84: 16.
22. Doyle H, Tzakis AG, Yunis E, Starzl TE. Smooth muscle tumor arising de novo in a liver allograft: a case report. Clin Transplant 1991; 5: 60.
23. Lee ES, Locker J, Nalesnik M, et al. The association of Epstein- Barr virus with smooth muscle tumors occurring after organ transplantation. N Engl J Med 1995; 332: 19.
24. Danhaive O, Minane J, Sokal E, et al. Hepatic localization of a fibrosarcoma in a child with a liver transplant. J Pediatr 1992; 120: 434.
25. Van Hoeven KH, Factor SM, Kress Y, et al. Visceral myogenic tumors: a manifestation of HIV infection in children. Amer. J Surg Pathol 1993; 17: 1176.
26. Mueller BU, Butler KM, Higham MC, et al. Smooth muscle tumors in children with human immunodeficiency virus infection. Pediatrics 1993; 91: 1020.
27. Templeton AC. Kaposi’s sarcoma. In: Andrade R, Gumport SL, Popkin GL, Rees TD, eds. Cancers of the skin: biology—diagnosis—management. Philadelphia: Saunders 1976: 1183.
28. Brooks JJ, Kaposi’s sarcoma. A reversible hyperplasia. Lancet 1986; 2: 1309.
29. Dalgleish AG. Kaposi’s sarcoma. Br J Cancer 1991; 64: 3.
30. Huang YQ, Li JJ, Rush MG, et al. HPV-16-related DNA sequences in Kaposi’s sarcoma. Lancet 1992; 339: 515.
31. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi’s sarcoma in patients with and those without HIV infection. N Engl J Med 1995; 332: 1181.
32. Roizman B. New viral footprints in Kaposi’s sarcoma. N Engl J Med 1995; 332: 1227.
33. Warner TF, O’Loughlin S. Kaposi’s sarcoma: a byproduct of tumor rejection. Lancet 1975; 2: 687.
34. Hanto DW. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med 1995; 46: 381.
35. Timmons CF, Dawson DB, Richards S, Andrews WA, Katz JA. Epstein-Barr virus-associated leiomyosarcomas in liver transplant recipients: origin from either donor or recipient tissue. Cancer (in press).
36. McLain KL, Leach CT, Jenson HB, et al. Association of Epstein- Barr virus with leiomyosarcoma in young people with AIDS. N Engl J Med 1995; 332: 12.
37. Zielger JL. Etiology: angiogenesis. In Ziegler JL, Dorfman RF, eds. Kaposi’s sarcoma: pathophysiology and clinical management. New York: Dekker, 1988: 151.
38. Pober JS, Collins T, Gimbrone MA, et al. Lymphocytes recognize human vascular endothelial and dermal fibroblast la antigens induced by recombinant interferon. Nature 1983; 305: 726.
39. Brunson ME, Balakrishnan K, Penn, I. HLA and Kaposi’s sarcoma in solid organ transplantation. Hum Immunol 1990; 29: 56.
40. Safai B, Mike V, Giraldo G, Beth E, Good RA. Association of Kaposi’s sarcoma with second primary malignancies: possible etiopathogenic implications. Cancer 1980; 45: 1472.
41. Safai B, Diaz B, Schwartz J. Malignant neoplasms associated with human immunodeficiency virus infection. CA Cancer J Clin 1992; 42: 74.
42. Touraine JL, Garnier JL, LeFrancois N, et al. Severe lympho- proliferative disease and Kaposi’s sarcoma in transplant patients. Transplant Proc 1989; 21: 3197.
43. Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy lymphedema: a report of six cases in elephantiasis chirurgica. Cancer 1948; 1: 64.
44. Alessi E, Sala F, Berti E. Angiosarcoma in lymphedematous limbs. Am J Dermatopathol 1986; 8: 371.
45. Weiss WM, Riles TS, Gouge TH, Mizrachi HH. Angiosarcoma at the site of dacron vascular prosthesis: a case report and literature review. J Vase Surg 1991; 14: 87.
46. Jennings TA, Peterson L, Axiotis CA, Friedlaender GE, Cooke RA, Rosai J. Angiosarcoma associated with foreign body material: a report of three cases. Cancer 1988; 62: 2436.
47. Penn I. Second malignancies following radiotherapy or chemotherapy for cancer. In Dubois JB, Serrou B, Rosenfeld C. eds. Immunopharmacologic effects of radiation therapy. New York, Raven Press 1981: 415.
48. Hatfield PM, Schulz MD. Postirradiation sarcoma, including five cases after X-ray therapy of breast carcinoma. Radiology 1970; 96: 593.